Ufp Technologies (UFPT) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.00 |
| Dec 31, 2025 | 100.00 |
| Sep 30, 2025 | 203.00 |
| Jun 30, 2025 | 785.00 |
| Mar 31, 2025 | 266.00 |
| Dec 31, 2024 | -535.00 |
| Sep 30, 2024 | -42.00 |
| Jun 30, 2024 | -65.00 |
| Mar 31, 2024 | 43.00 |
| Dec 31, 2023 | 172.00 |
| Sep 30, 2023 | -149.00 |
| Jun 30, 2023 | 35.00 |
| Mar 31, 2023 | 449.00 |
| Dec 31, 2022 | 621.00 |
| Sep 30, 2022 | 1,137.00 |
| Jun 30, 2022 | -252.00 |
| Mar 31, 2022 | -130.00 |
| Dec 31, 2021 | -47.00 |
| Sep 30, 2021 | -349.00 |
| Jun 30, 2021 | -175.00 |
| Mar 31, 2021 | 363.00 |
| Dec 31, 2020 | 326.00 |
| Sep 30, 2020 | -27.00 |
| Jun 30, 2020 | -253.00 |
| Mar 31, 2020 | 296.00 |
| Dec 31, 2019 | 639.00 |
| Sep 30, 2019 | 368.00 |
| Jun 30, 2019 | 459.00 |
| Mar 31, 2019 | 187.00 |
| Dec 31, 2018 | -438.00 |
| Sep 30, 2018 | -61.00 |
| Jun 30, 2018 | -136.00 |
| Mar 31, 2018 | -280.00 |
| Dec 31, 2017 | -826.00 |
| Sep 30, 2017 | -573.00 |
| Jun 30, 2017 | -241.00 |
| Mar 31, 2017 | -289.00 |
| Dec 31, 2016 | -722.00 |
| Sep 30, 2016 | 35.00 |
| Jun 30, 2016 | -182.00 |
| Mar 31, 2016 | -747.00 |
| Dec 31, 2015 | -646.00 |
| Sep 30, 2015 | -361.00 |
| Jun 30, 2015 | -270.00 |